New oral anticoagulants: dosing and monitoring
BMJ
.
2015 May 19:350:h2655.
doi: 10.1136/bmj.h2655.
Authors
Jignesh P Patel
1
,
Lewis Couchman
2
,
Paradzai B Chitongo
3
,
Robert J Flanagan
2
,
Roopen Arya
4
Affiliations
1
Department of Haematological Medicine, King's College Hospital, London SE5 9RS, UK jig.patel@kcl.ac.uk.
2
Viapath Analytics, Toxicology Unit, Department of Clinical Biochemistry, King's College Hospital.
3
Haemostasis and Thrombosis Laboratory, King's College Hospital.
4
Department of Haematological Medicine, King's College Hospital, London SE5 9RS, UK.
PMID:
25991429
DOI:
10.1136/bmj.h2655
No abstract available
Publication types
Letter
MeSH terms
Administration, Oral
Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Drug Administration Schedule
Gastrointestinal Hemorrhage / chemically induced
Humans
Practice Guidelines as Topic
Substances
Anticoagulants